Mirae Asset Global Investments Co., Ltd. Syndax Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,537 shares of SNDX stock, worth $47,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,537
Previous 40,268
93.7%
Holding current value
$47,416
Previous $958,000
94.57%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SNDX
# of Institutions
201Shares Held
87MCall Options Held
268KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$148 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$137 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$107 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$89.7 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.89MShares$72.7 Million1.09% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.06B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...